Eupraxia Pharmaceuticals Reports Fourth Quarter and 2022 Financial Results
VICTORIA, BC, March 23, 2023 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") EPRX, a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced its audited …